Detalhe da pesquisa
1.
Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib vs Paclitaxel Alone in Patients With Platinum-Resistant Ovarian High-Grade Serous Carcinoma: The OCTOPUS Multicenter, Phase 2, Randomized Clinical Trial.
JAMA Oncol
; 9(5): 675-682, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928279
2.
The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
Nat Commun
; 14(1): 4387, 2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37474499
3.
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin.
Cancer Res
; 82(23): 4457-4473, 2022 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206301
4.
Author Correction: The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
Nat Commun
; 14(1): 5992, 2023 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752102